Search company, investor...

Founded Year

2005

Stage

Series H | Alive

Total Raised

$172.02M

Last Raised

$26M | 9 mos ago

About Vertos Medical

Vertos Medical operates as a medical device company. It focuses on developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its technologies include Mild, which offers a guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. The company was formerly known as X-Sten. It was founded in 2005 and is based in Aliso Viejo, California.

Headquarters Location

95 Enterprise Suite 325

Aliso Viejo, California, 92656,

United States

877-958-6227

Loading...

Loading...

Vertos Medical Patents

Vertos Medical has filed 23 patents.

The 3 most popular patent topics include:

  • bones of the vertebral column
  • neurosurgery
  • glucocorticoids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/8/2020

5/3/2022

Bones of the vertebral column, Orthopedic surgical procedures, Surgical removal procedures, Neurosurgery, Skeletal system

Grant

Application Date

4/8/2020

Grant Date

5/3/2022

Title

Related Topics

Bones of the vertebral column, Orthopedic surgical procedures, Surgical removal procedures, Neurosurgery, Skeletal system

Status

Grant

Latest Vertos Medical News

Vertos Medical, Inc. Ranked Number 370 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Nov 8, 2023

News provided by Share this article Share toX Attributes the company's remarkable 343% revenue growth to its innovation and unwavering commitment to enhancing the quality of patients' lives. ALISO VIEJO, Calif., Nov. 8, 2023 /PRNewswire/ -- Vertos Medical today announced it ranked 370 on the Deloitte Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 29th year. Vertos Medical grew 343% between 2019 and 2022. Vertos Medical's Chief Executive Officer, Eric Wichems, credits the company's tremendous 343% revenue growth during this period to the team's unwavering commitment to delivering a treatment option for patients with lumbar spinal stenosis, while experiencing an increase in demand for the groundbreaking mild® Procedure. A successful $26 million Series C equity funding round in June bolstered the company's commercial expansion, and the promotion of two senior leaders to C-Suite roles will further drive product innovation and patient access. Wichems said, "We're honored to receive recognition for a second year in a row as one of North America's fastest-growing companies. What is truly meaningful is that we've had the ability to improve the quality of life for thousands of patients through collaboration with our healthcare partners. I take immense pride in our team's exceptional performance; none of this would have been achievable without the profound dedication of each employee, driven by a deep passion to better the lives of millions of patients grappling with chronic low back pain." Vertos Medical previously ranked 384 as a Technology Fast 500 award winner for 2022. Overall, the 2023 Technology Fast 500 companies achieved revenue growth ranging from 201% to 222,189% over the three-year time frame from 2019 to 2022, with an average growth rate of 1,934% and a median growth rate of 497%. About the 2023 Deloitte Technology Fast 500 Now in its 29th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies—both public and private—in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2019 to 2022. In order to be eligible for Technology Fast 500 recognitions, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America. About Vertos Medical Inc. and the mild® Procedure Vertos Medical is an interventional pain company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). mild®, its proprietary technology, is an image-guided outpatient procedure that removes a major root cause of lumbar spinal stenosis (LSS) through an incision smaller than the size of baby aspirin and doesn't require implants, general anesthesia, or stitches. The mild® Procedure has been clinically demonstrated to have safety outcomes similar to injections with durability out to 5 years, and patients typically return to activities of daily living within 24 hours with no restrictions. mild® is nationally covered by Medicare. Vertos Medical headquarters is located in Aliso Viejo, CA. To learn more and view clinical data, visit www.Vertosmed.com . About Deloitte Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters  by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future . Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte's approximately 457,000 people worldwide connect for impact at www.deloitte.com . CONTACT:

Vertos Medical Frequently Asked Questions (FAQ)

  • When was Vertos Medical founded?

    Vertos Medical was founded in 2005.

  • Where is Vertos Medical's headquarters?

    Vertos Medical's headquarters is located at 95 Enterprise, Aliso Viejo.

  • What is Vertos Medical's latest funding round?

    Vertos Medical's latest funding round is Series H.

  • How much did Vertos Medical raise?

    Vertos Medical raised a total of $172.02M.

  • Who are the investors of Vertos Medical?

    Investors of Vertos Medical include Pitango Venture Capital, MVM Partners, Norwest Venture Partners, Revelation Partners, ONSET Ventures and 8 more.

  • Who are Vertos Medical's competitors?

    Competitors of Vertos Medical include NeoChord, Endologix, Spine Wave, Invuity, Vexim and 7 more.

Loading...

Compare Vertos Medical to Competitors

K
Kyphon

Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. It offers balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. The company was founded in 1994 and is based in Sunnyvale, California.

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation, and is proven to resolve and restore normal mitral valve function. It was formerly known as mValve. The company was founded in 2007 and is based in St. Louis Park, Minnesota.

D
Disc Dynamics

Disc Dynamics is an orthopedic spine company focused on providing minimally invasive surgical alternatives for treating degenerative disc disease. The company's main offering is the DASCOR Disc Arthroplasty System, a catheter-based nucleus replacement technology designed to treat degenerated lumbar discs by relieving pain, restoring function, and preserving anatomy. It was founded in 2000 and is based in Eden Prairie, Minnesota.

Ecochlor Logo
Ecochlor

Ecochlor is a company that specializes in environmental marine technology, specifically in the domain of ballast water treatment systems. The company offers a two-step treatment process for ballast water, which includes filtration and the use of chlorine dioxide, providing a solution that is not affected by changes in salinity, temperature, turbidity, or organics. The company primarily serves the maritime industry. It is based in Maynard, Massachusetts.

B
Biospiral

BioSpiral's state-of-art system aims to provide prostate cancer treatment as a minimally invasive procedure, which uses cooling & heating technologies to destroy prostate cancer.nBioSpiral was established in Sep 2006 and is operating as part of NGT Incubator. nBioSpiral prostate thermodynamics therapy is an effective, minimally invasive treatment for prostate cancer that does not involve the difficulty and complications associated with surgery, nor the harmful properties of radiation or cryotherapy .The system revolutionizes prostate cancer treatment by introducing a "one shot" treatment method under local anesthesia at the physician's clinic. BioSpiral treatment is for patients with localized prostate cancer, who look for an effective minimal invasive therapy for prostate cancer. Additionally, this treatment can also be used by patients who have local recurrence after other treatments ("salvage" treatment). Key advantages:nCost effective: short treatment, no need for O.R or hospitalizationnHighly efficient: tissue ablationnPatients: high quality of life; minimal side effects, minimal invasive, short treatment & recovery.

Cardious Logo
Cardious

Cardious is a medical device company organized to develop and commercialize the AvA Aortic Valve Bypass Graft System for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.